Reaction Details Report a problem with these data
Target
Integrase
Ligand
BDBM294739
Substrate
n/a
Meas. Tech.
Anti-HIV Activity MT4 Assay
IC50
3.00±n/a nM
Citation
 Johns, BA; Velthuisen, EJ; Weatherhead, JG; Suwandi, L; Temelkoff, D Isoindoline derivatives for use in the treatment of a viral infection US Patent  US10112899 Publication Date 10/30/2018 
Target
Name:
Integrase
Synonyms:
Human immunodeficiency virus type 1 integrase
Type:
PROTEIN
Mol. Mass.:
32231.48
Organism:
Human immunodeficiency virus 1
Description:
ChEMBL_90865
Residue:
288
Sequence:
FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED
  
Inhibitor
Name:
BDBM294739
Synonyms:
(S)-2-(tert-butoxy)-2-((M)-2-(4,4-difluoropiperidine-1-carbon yl)-6-(8-fluoro-5-methylchroman-6-yl)-4,7-dimethylisoindolin-5-yl)acetic acid | US10112899, Example 213
Type:
Small organic molecule
Emp. Form.:
C32H39F3N2O5
Mol. Mass.:
588.6577
SMILES:
Cc1c2CN(Cc2c(C)c(-c2cc(F)c3OCCCc3c2C)c1[C@H](OC(C)(C)C)C(O)=O)C(=O)N1CCC(F)(F)CC1 |r,wD:23.27,(4.29,-2.84,;2.95,-2.07,;1.62,-2.84,;1.3,-4.34,;-.23,-4.51,;-.86,-3.1,;.29,-2.07,;.29,-.53,;-1.05,.24,;1.62,.24,;1.62,1.78,;2.95,2.55,;2.95,4.09,;4.29,4.86,;1.62,4.86,;1.62,6.4,;.29,7.17,;-1.05,6.4,;-1.05,4.86,;.29,4.09,;.29,2.55,;-1.05,1.78,;2.95,-.53,;4.29,.24,;4.29,1.78,;5.62,2.55,;6.96,3.32,;5.62,4.09,;6.96,1.78,;5.62,-.53,;6.96,.24,;5.62,-2.07,;-1,-5.84,;-.23,-7.17,;-2.54,-5.84,;-3.31,-4.51,;-4.85,-4.51,;-5.62,-5.84,;-6.96,-6.61,;-6.96,-5.07,;-4.85,-7.17,;-3.31,-7.17,)|
Structure:
Search PDB for entries with ligand similarity: